Carbon Dioxide vs. Air Insufflation for Pediatric Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Carbon dioxide (CO) insufflation during gastrointestinal (GI) endoscopic procedures has gained popularity in adults. However, its utility in pediatric patients is not known. The current review aimed to compare the efficacy of CO vs. air insufflation for GI endoscopic procedures in pediatric patients. The electronic databases of PubMed, Embase, Scopus, and CENTRAL were searched from the inception of databases to 15th August 2020. All randomized controlled trials (RCTs) comparing CO vs. air insufflation for GI endoscopic procedures in pediatric patients were eligible for inclusion. Five RCTs were identified. Pooled analysis of data from 226 patients in the CO group and 224 patients in the air group revealed that patients receiving CO insufflation were at a lower odds of experiencing postoperative pain as compared to those undergoing the procedure with air (OR: 0.40; 95% CI: 0.19, 0.87; = 62%; = 0.02). Descriptive analysis indicated no difference in the two groups for abdominal distention after the procedure. Two trials reported elevated CO in the study group but without any pulmonary complications. Bloating was reported by two studies and both reported significantly less bloating in the CO group. Our study indicates that the incidence of pain may be reduced with the use of CO insufflation in pediatric GI endoscopies without a significant risk of adverse events. However, current evidence is from a limited number of trials and not strong to recommend a routine of CO in pediatric gastroenterology practice. Further high-quality RCTs are required to supplement current evidence.